We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+7.48%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$111B
AUM Growth
+$4.45B
(+4.2%)
Cap. Flow
-$1.78B
Cap. Flow
% of AUM
-1.61%
Top 10 Holdings %
Top 10 Hldgs %
29%
Holding
4,480
New
63
Increased
1,265
Reduced
2,421
Closed
236
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$46M |
| 2 |
Palantir
PLTR
|
+$40.3M |
| 3 |
SW
Smurfit Westrock
SW
|
+$39.2M |
| 4 |
Dell
DELL
|
+$29.2M |
| 5 |
Avantor
AVTR
|
+$27.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$97.8M |
| 2 |
Eli Lilly
LLY
|
+$58.2M |
| 3 |
NVIDIA
NVDA
|
+$48.6M |
| 4 |
ExxonMobil
XOM
|
+$31.3M |
| 5 |
Bank of America
BAC
|
+$30.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.19% |
| 2 | Financials | 12.91% |
| 3 | Healthcare | 11.38% |
| 4 | Consumer Discretionary | 10.81% |
| 5 | Industrials | 9.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KALV
2501
DELISTED
KalVista Pharmaceuticals
KALV
| $582K | ﹤0.01% |
50,279
-2,949
| -6% | -$37.1K |
|
2502
Zumiez
ZUMZ
$334M
| $581K | ﹤0.01% |
27,297
-253
| -0.9% | -$6.05K |
|
2503
Erasca
ERAS
$6.27B
| $580K | ﹤0.01% |
212,488
+57,873
| +37% | +$163K |
|
2504
Entrada Therapeutics
TRDA
$269M
| $580K | ﹤0.01% |
36,298
-642
| -2% | -$10.1K |
|
2505
Sierra Bancorp
BSRR
$516M
| $580K | ﹤0.01% |
20,079
-866
| -4% | -$24.1K |
|
2506
Greenlight Captial
GLRE
$505M
| $578K | ﹤0.01% |
42,371
-3,503
| -8% | -$46.7K |
|
2507
RBB Bancorp
RBB
$450M
| $577K | ﹤0.01% |
25,046
-30
| -0.1% | -$655 |
|
2508
3D Systems Corp
DDD
$615M
| $576K | ﹤0.01% |
202,955
-150,192
| -43% | -$432K |
|
2509
Movado Group
MOV
$829M
| $576K | ﹤0.01% |
30,967
-19,992
| -39% | -$460K |
|
|
CMRC
2510
Commerce.com Inc Series 1
CMRC
$176M
| $576K | ﹤0.01% |
98,440
-3,116
| -3% | -$20.6K |
|
|
ENFN
2511
DELISTED
Enfusion, Inc.
ENFN
| $576K | ﹤0.01% |
60,668
+1,233
| +2% | +$10.6K |
|
|
CTLP
2512
DELISTED
Cantaloupe
CTLP
| $575K | ﹤0.01% |
77,752
-4,607
| -6% | -$31.7K |
|
|
ACRE
2513
Ares Commercial Real Estate
ACRE
$255M
| $575K | ﹤0.01% |
82,096
-4,370
| -5% | -$31.4K |
|
|
FARO
2514
DELISTED
Faro Technologies
FARO
| $573K | ﹤0.01% |
29,946
-1,749
| -6% | -$29.5K |
|
2515
State Street SPDR S&P 500 ETF Trust
SPY
$810B
| $573K | ﹤0.01% |
998
| – | – |
|
2516
Stoke Therapeutics
STOK
$2.08B
| $573K | ﹤0.01% |
46,587
-1,273
| -3% | -$18K |
|
2517
Vishay Precision Group
VPG
$873M
| $572K | ﹤0.01% |
22,069
-846
| -4% | -$24.1K |
|
2518
Ardagh Metal Packaging
AMBP
$2.95B
| $571K | ﹤0.01% |
151,481
-14,097
| -9% | -$49.8K |
|
2519
El Pollo Loco
LOCO
$468M
| $570K | ﹤0.01% |
41,622
-1,554
| -4% | -$19.5K |
|
2520
Marcus Corp
MCS
$919M
| $569K | ﹤0.01% |
37,779
-3,424
| -8% | -$45.1K |
|
|
PPTA
2521
Perpetua Resources
PPTA
$3.12B
| $565K | ﹤0.01% |
60,435
+10,985
| +22% | +$81.5K |
|
2522
Canadian Pacific Kansas City
CP
$79.7B
| $564K | ﹤0.01% |
6,588
| – | – |
|
2523
CorMedix
CRMD
$585M
| $563K | ﹤0.01% |
69,719
-4,520
| -6% | -$24.5K |
|
2524
RCI Hospitality Holdings
RICK
$209M
| $563K | ﹤0.01% |
12,642
-352
| -3% | -$15.8K |
|
2525
Boston Omaha
BOC
$431M
| $563K | ﹤0.01% |
37,862
-2,046
| -5% | -$28.5K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2024 Portfolio in Review
As of Q3 2024, RhumbLine Advisers held 4,480 positions worth $111B, up 4.2% from $106B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
RhumbLine Advisers's Q3 2024 filing shows 63 new, 1,265 increased, 2,421 reduced and 236 closed positions. Its largest new stake was Smurfit Westrock: 860,959 shares worth $42.5M. The largest sale was Microsoft, an estimated $97.8M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2024 buy was Smurfit Westrock: 860,959 shares worth $42.5M.
- RhumbLine Advisers added most to Apple in Q3 2024, an estimated $46M increase.
- RhumbLine Advisers's biggest Q3 2024 reduction was Microsoft, cutting an estimated $97.8M.
- RhumbLine Advisers fully exited Expand Energy Corp in Q3 2024, selling an estimated $27.4M.
- RhumbLine Advisers's ten largest holdings make up 29% of its $111B portfolio in Q3 2024.
- RhumbLine Advisers opened 63 new positions and closed 236 in Q3 2024.
- RhumbLine Advisers's portfolio value rose 4.2% quarter-over-quarter to $111B.
Based on RhumbLine Advisers's 13F filing for Q3 2024, filed 12 Nov 2024.